AbbVie wins second AndroGel liability reversal
A U.S. judge overturned a $140.1 million verdict against AbbVie in a lawsuit by a man who claimed the drugmaker misrepresented the risks of its testosterone replacement drug AndroGel. (Source: PharmaManufacturing.com)
Source: PharmaManufacturing.com - July 9, 2018 Category: Pharmaceuticals Source Type: news

AbbVie wins reversal of $140 million verdict in case over AndroGel risks
A U.S. judge on Thursday overturned a $140.1 million verdict against AbbVie Inc in a lawsuit by a man who claimed the company misrepresented the risks of its testosterone replacement drug AndroGel, causing him to suffer a heart attack. (Source: Reuters: Health)
Source: Reuters: Health - July 6, 2018 Category: Consumer Health News Tags: healthNews Source Type: news

AbbVie wins reversal of $140 million verdict in case over AndroGel risks
(Reuters) - A U.S. judge on Thursday overturned a $140.1 million verdict against AbbVie Inc in a lawsuit by a man who claimed the company misrepresented the risks of its testosterone replacement drug AndroGel, causing him to suffer a heart attack. (Source: Reuters: Health)
Source: Reuters: Health - July 5, 2018 Category: Consumer Health News Tags: healthNews Source Type: news

U.S. judge tosses $140 million verdict against AbbVie in AndroGel case
(Reuters) - A U.S. judge on Thursday overturned a $140 million verdict against AbbVie Inc in a lawsuit by a man who claimed the company misrepresented the risks of its testosterone replacement drug AndroGel, causing him to suffer a heart attack. (Source: Reuters: Health)
Source: Reuters: Health - July 5, 2018 Category: Consumer Health News Tags: healthNews Source Type: news

AbbVie, AndroGel partner owe $448 million in antitrust case: U.S. judge
(Reuters) - A U.S. judge on Friday found that pharmaceutical company AbbVie Inc used sham litigation to illegally prevent generic versions of testosterone replacement drug AndroGel from getting to market and ordered the drugmaker and its partner to pay $448 million. (Source: Reuters: Health)
Source: Reuters: Health - June 30, 2018 Category: Consumer Health News Tags: healthNews Source Type: news

Abbvie, Androgel partner owe $488 million in antitrust case: U.S. judge
(Reuters) - A U.S. judge on Friday found that Abbvie Inc used sham litigation to illegally prevent generic versions of testosterone gel AndroGel from getting to market and ordered the drugmaker and its partner to pay $488 million. (Source: Reuters: Health)
Source: Reuters: Health - June 29, 2018 Category: Consumer Health News Tags: healthNews Source Type: news

U.S. Jury Orders AbbVie to Pay $3 Mln in AndroGel Retrial U.S. Jury Orders AbbVie to Pay $3 Mln in AndroGel Retrial
A U.S. jury ordered AbbVie to pay more than $3 million to a man who claimed the company misrepresented the risks of its testosterone replacement drug AndroGel, causing him to suffer a heart attack, though the jury did not find AbbVie strictly liable.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - March 27, 2018 Category: Consumer Health News Tags: Diabetes & Endocrinology News Source Type: news

U.S. jury orders AbbVie to pay $3 million in AndroGel retrial
NEW YORK (Reuters) - A U.S. jury on Monday ordered AbbVie Inc to pay more than $3 million to a man who claimed the company misrepresented the risks of its testosterone replacement drug AndroGel, causing him to suffer a heart attack, though the jury did not find AbbVie strictly liable. (Source: Reuters: Health)
Source: Reuters: Health - March 26, 2018 Category: Consumer Health News Tags: healthNews Source Type: news

AbbVie Wins U.S. Trial in Lawsuit Over AndroGel's Risks AbbVie Wins U.S. Trial in Lawsuit Over AndroGel's Risks
A federal jury in Chicago on Friday found AbbVie Inc not liable in a lawsuit by an Arizona man who claimed he had suffered a pulmonary embolism due to using the company's testosterone replacement medication AndroGel.Reuters Health Information (Source: Medscape Diabetes Headlines)
Source: Medscape Diabetes Headlines - January 31, 2018 Category: Endocrinology Tags: Diabetes & Endocrinology News Source Type: news

AbbVie wins U.S. trial in lawsuit over AndroGel's risks
(Reuters) - A federal jury in Chicago on Friday found AbbVie Inc not liable in a lawsuit by an Arizona man who claimed he had suffered a pulmonary embolism due to using the company's testosterone replacement medication AndroGel. (Source: Reuters: Health)
Source: Reuters: Health - January 27, 2018 Category: Consumer Health News Tags: healthNews Source Type: news

U.S. judge tosses verdict against AbbVie in AndroGel case
(Reuters) - A U.S. judge on Friday overturned a $150 million verdict against AbbVie Inc that was first to result from lawsuits claiming that the company fraudulently misrepresented the risks of its testosterone replacement drug AndroGel. (Source: Reuters: Health)
Source: Reuters: Health - December 22, 2017 Category: Consumer Health News Tags: healthNews Source Type: news

U.S. judge tosses $150 million verdict against AbbVie in AndroGel case
(Reuters) - A U.S. judge on Friday overturned a $150 million verdict against AbbVie Inc in the first federal court case to go to trial over claims that the company fraudulently misrepresented the risks of its testosterone replacement drug AndroGel. (Source: Reuters: Health)
Source: Reuters: Health - December 22, 2017 Category: Consumer Health News Tags: healthNews Source Type: news

Testosterone Gel Packets (New - Discontinuation)
Drug Shortage (Source: FDA Drug Shortages)
Source: FDA Drug Shortages - November 6, 2017 Category: Drugs & Pharmacology Source Type: news

Second U.S. jury finds AbbVie misrepresented risks of AndroGel
(Reuters) - A U.S. jury on Thursday ordered AbbVie Inc to pay more than $140 million to a man who claimed the company misrepresented the risks of its testosterone replacement drug AndroGel, causing him to suffer a heart attack, the plaintiff's lawyer said in a statement. (Source: Reuters: Health)
Source: Reuters: Health - October 5, 2017 Category: Consumer Health News Tags: healthNews Source Type: news

AbbVie hit with $140 million verdict in AndroGel trial: lawyer
(Reuters) - A U.S. jury on Thursday ordered AbbVie Inc to pay more than $140 million to a man who claimed the company misrepresented the risks of its testosterone replacement drug AndroGel, causing him to suffer a heart attack, the plaintiff's lawyer said in an emailed statement. (Source: Reuters: Health)
Source: Reuters: Health - October 5, 2017 Category: Consumer Health News Tags: healthNews Source Type: news

Dose-Response Effects of T Gel in Medically Castrated Men Dose-Response Effects of T Gel in Medically Castrated Men
A new study examines the treatment effects of variable doses of transdermal testosterone gel among medically castrated men.Clinical Endocrinology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - September 21, 2017 Category: Consumer Health News Tags: Diabetes & Endocrinology Journal Article Source Type: news

U.S. Jury Finds AbbVie Liable for Misrepresentation in First AndroGel Verdict U.S. Jury Finds AbbVie Liable for Misrepresentation in First AndroGel Verdict
A federal jury in Chicago on Monday found AbbVie Inc fraudulently misrepresented the risks of its testosterone replacement drug AndroGel and ordered the drugmaker to pay $150 million in punitive damages.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - July 25, 2017 Category: Consumer Health News Tags: Medscape Today News Source Type: news

U.S. jury finds AbbVie liable for misrepresentation in AndroGel verdict
NEW YORK (Reuters) - A federal jury in Chicago on Monday found AbbVie Inc fraudulently misrepresented the risks of its testosterone replacement drug AndroGel and ordered the drugmaker to pay $150 million in punitive damages. (Source: Reuters: Health)
Source: Reuters: Health - July 24, 2017 Category: Consumer Health News Tags: healthNews Source Type: news

U.S. jury finds AbbVie liable for misrepresentation in first AndroGel verdict
NEW YORK (Reuters) - A federal jury in Chicago on Monday found AbbVie Inc fraudulently misrepresented the risks of its testosterone replacement drug AndroGel and ordered the drugmaker to pay $150 million in punitive damages. (Source: Reuters: Health)
Source: Reuters: Health - July 24, 2017 Category: Consumer Health News Tags: healthNews Source Type: news

Testosterone Replacement Gel Therapy for Male Hypogonadism Testosterone Replacement Gel Therapy for Male Hypogonadism
This novel testosterone gel formulation may be an effective new treatment option for hypogonadal men.Endocrine Practice (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - July 14, 2017 Category: Consumer Health News Tags: Diabetes & Endocrinology Journal Article Source Type: news

Axiron vs. Androgel
Title: Axiron vs. AndrogelCategory: MedicationsCreated: 4/19/2017 12:00:00 AMLast Editorial Review: 4/19/2017 12:00:00 AM (Source: MedicineNet Medications General)
Source: MedicineNet Medications General - April 19, 2017 Category: Drugs & Pharmacology Source Type: news

Axiron vs. Androgel Testosterone Supplements
Title: Axiron vs. Androgel Testosterone SupplementsCategory: MedicationsCreated: 4/18/2017 12:00:00 AMLast Editorial Review: 4/18/2017 12:00:00 AM (Source: MedicineNet Medications General)
Source: MedicineNet Medications General - April 18, 2017 Category: Drugs & Pharmacology Source Type: news

Morning Report: Vertigo, Insect Repellents, Testosterone Gel Morning Report: Vertigo, Insect Repellents, Testosterone Gel
Dr Arefa Cassoobhoy highlights some of this week's most important medical news.Medscape Internal Medicine (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - March 10, 2017 Category: Consumer Health News Tags: Internal Medicine Commentary Source Type: news

Testosterone Therapy: Five New Reports Offer a Mixed Bag (FREE)
By Amy Orciari Herman Edited by David G. Fairchild, MD, MPH New findings from the NIH-supported " Testosterone Trials " offer a mixed take on the potential role of testosterone therapy in older men. In the trials, men aged 65 and older with serum testosterone below 275 ng/dL plus sexual or physical dysfunction or reduced vitality were randomized to use testosterone gel (1%) or placebo for 1 year.Among the findings, as reported … (Source: Physician's First Watch current issue)
Source: Physician's First Watch current issue - February 21, 2017 Category: Primary Care Source Type: news

Testosterone gel study finds no memory benefit
Testosterone treatment did not improve older men's memory or mental function, according to a new study (Source: Health News: CBSNews.com)
Source: Health News: CBSNews.com - February 21, 2017 Category: Consumer Health News Source Type: news

Fortesta (Testosterone Gel) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - November 9, 2016 Category: Drugs & Pharmacology Source Type: news

Vogelxo (Testosterone Gel) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - November 9, 2016 Category: Drugs & Pharmacology Source Type: news

AndroGel 1.62 (Testosterone Gel) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - November 7, 2016 Category: Drugs & Pharmacology Source Type: news

AndroGel (Testosterone Gel for Topical Use) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - November 7, 2016 Category: Drugs & Pharmacology Source Type: news

Testim (Testosterone Gel) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - October 31, 2016 Category: Drugs & Pharmacology Source Type: news

Testosterone gel boosts sexual desire and activity in older men
(Reuters Health) - Older men with low testosterone levels and scant desire for sex report more interest and more sexual activity after testosterone therapy, according to a new study. (Source: Reuters: Health)
Source: Reuters: Health - July 4, 2016 Category: Consumer Health News Tags: healthNews Source Type: news

Testosterone Therapy May Boost Older Men's Sex Lives
WEDNESDAY, June 29, 2016 -- Aging men who are losing their sexual pep can receive a love-life boost from testosterone replacement therapy, according to results from the largest "low-T" clinical trial to date. Older men treated with testosterone gel... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - June 29, 2016 Category: Journals (General) Source Type: news

Medical News Today: Testosterone gel boosts sexual function, mood for older men
Early results from the largest trials of testosterone therapy to date reveals that a testosterone gel improved sexual function, mood and walking ability for men aged 65 and older. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - February 19, 2016 Category: Consumer Health News Tags: Men's Health Source Type: news

Testosterone gel is no fountain of youth, study finds
New study shows certain benefits of the therapy, while questions about risks still remain (Source: Health News: CBSNews.com)
Source: Health News: CBSNews.com - February 18, 2016 Category: Consumer Health News Source Type: news

Testosterone Therapy Boosts Libido In Older Men -- But Not This
  Could this be the male version of "I'm not in the mood, Honey?"  A University of Pennsylvania study published in the New England Journal of Medicine found that men 65 and older responded favorably when treated with a gel containing the male hormone testosterone inasmuch as they saw modest gains in their sex drive. But the treatments did little to improve their vitality or how far they could walk.  The gel was tested in seven different trials. The new report looked only at the trials that assessed the impact of the testosterone gel on sexual function, physical function and vitality. Data on its ...
Source: Healthy Living - The Huffington Post - February 18, 2016 Category: Consumer Health News Source Type: news

Testosterone gel has modest effect for older men
Stephen FellerPHILADELPHIA, Feb. 18 (UPI) -- A recent set of studies found testosterone replacement for men over 65 modestly improves sexual function, walking ability, and mood, researchers reported. (Source: Health News - UPI.com)
Source: Health News - UPI.com - February 18, 2016 Category: Consumer Health News Source Type: news

Testosterone gel has modest benefits for men
Research published in the New England Journal of Medicine suggest testosterone gel may provide only modest benefits and that more conservative use should be suggested. NY Times (Source: Society for Endocrinology)
Source: Society for Endocrinology - February 18, 2016 Category: Endocrinology Source Type: news

Testosterone Treatment Shown to Benefit Men Over 65
University of Pittsburgh Graduate School of Public Health was among a dozen sites in the first clinical trial to show testosterone gel improves sexual function in men over 65.(PRWeb February 17, 2016)Read the full story at http://www.prweb.com/releases/2016/02/prweb13213974.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - February 18, 2016 Category: Pharmaceuticals Source Type: news

Testosterone Gel Has Modest Benefits for Men, Study Says
Using the gel seemed to improve sexual functioning, but little else, in landmark research published Wednesday in The New England Journal of Medicine. (Source: NYT Health)
Source: NYT Health - February 17, 2016 Category: Consumer Health News Authors: GINA KOLATA Tags: National Institutes of Health Drugs (Pharmaceuticals) Hormones Men Over 65 AbbVie Inc Testosterone Source Type: news

Study finds testosterone gel is no fountain of youth
CHICAGO (AP) — A landmark study suggests that testosterone treatment is no fountain of youth, finding mostly modest improvement in the sex lives, walking strength and mood of a select group of older men. (Source: U.S. News - Health)
Source: U.S. News - Health - February 17, 2016 Category: Consumer Health News Source Type: news

Testosterone Boosts Libido And Mood In Study -- But Beware Of Caveats
A key study credits AbbVie's AndroGel testosterone drug for improving the sex lives of older men and other benefits, but that doesn't mean everyone should rush out and get prescriptions for the hormone. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - February 17, 2016 Category: Pharmaceuticals Authors: Arlene Weintraub Source Type: news

How The 'Low T' Wars Cast A Shadow Over Repros' Testosterone Alternative
Repros is trying to win approval for a pill that it believes can raise testosterone levels without the downsides of drugs like AbbVie's AndroGel. The FDA, however, seems to have serious doubts. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - November 3, 2015 Category: Pharmaceuticals Authors: Arlene Weintraub Source Type: news

Testosterone Suits Soar Past 2,500 As Legal Milestone Looms for AbbVie
Sales of AbbVie's embattled testosterone drug AndroGel fell in what was otherwise a strong quarter for the company. Now AbbVie is facing the selection of the bellwether cases to be tried next year involving men who believe they were harmed by the gel. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - October 30, 2015 Category: Pharmaceuticals Authors: Arlene Weintraub Source Type: news

Estrogen Modulator Boosts T in Hypogonadal Men, Trial Finds (CME/CE)
(MedPage Today) -- Phase III study compared novel oral agent with testosterone gel (Source: MedPage Today Endocrinology)
Source: MedPage Today Endocrinology - October 29, 2015 Category: Endocrinology Source Type: news

Restoring testosterone rather than replacing it helps safeguard a man's fertility
Restoring testosterone production in men may be as effective as replacing it, without compromising their fertility. Two phase III clinical trials show that a drug that restores the body's natural production of testosterone has no negative effect on a man's sperm count while a topical testosterone gel causes a significant drop. The findings could change the way men are treated for low testosterone. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - October 27, 2015 Category: Science Source Type: news

Restoring testosterone rather than replacing it helps safeguard a man's fertility
(Wiley) Restoring testosterone production in men may be as effective as replacing it, without compromising their fertility. Two phase III clinical trials show that a drug that restores the body's natural production of testosterone has no negative effect on a man's sperm count while a topical testosterone gel causes a significant drop. The findings, which are published in BJU International, could change the way men are treated for low testosterone. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - October 27, 2015 Category: Global & Universal Source Type: news

Attorneys for National Testosterone Lawsuits Provide Latest Court News
In national testosterone lawsuit news, the Onder Law Firm reports that the court deferred multiple claims against defendant Besins; counsel to set Discovery schedule for allegations of heart attack...(PRWeb October 05, 2015)Read the full story at http://www.prweb.com/releases/androgel-heart-attack/testosterone-lawsuit-news/prweb12998037.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - October 5, 2015 Category: Pharmaceuticals Source Type: news

Is treating “low T” really safe and effective?
An ongoing pharmaceutical marketing blitz promises that treating “low T” with a daily prescription testosterone boost will make men with age-related decline in this hormone feel more alert, energetic, mentally sharp, and fully functional in the bedroom. But in an article published this week in the Perspectives section of The New England Journal of Medicine, a group of FDA scientists reiterated concerns over the widespread use of testosterone supplements in light of unresolved controversies over its effectiveness and long-term safety. Is testosterone replacement therapy (TRT) delivering what these men expect it ...
Source: New Harvard Health Information - August 20, 2015 Category: Consumer Health News Authors: Daniel Pendick Tags: Men's Health low T testosterone Source Type: news

AbbVie Challenges Fairness Of Upcoming Testosterone Trials
As the lawsuits against testosterone makers continue to mount, AndroGel manufacturer AbbVie is raising questions about whether the process of picking the bellwether cases is fair enough. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - August 17, 2015 Category: Pharmaceuticals Authors: Arlene Weintraub Source Type: news

Testosterone Gel Not Associated with Subclinical Atherosclerosis Progression, Study Suggests (FREE)
By Kelly Young Edited by Lorenzo Di Francesco, MD, FACP, FHM Use of a testosterone gel in older men with lower testosterone levels was not associated with progression of subclinical atherosclerosis in an industry-funded study published in JAMA … (Source: Physician's First Watch current issue)
Source: Physician's First Watch current issue - August 12, 2015 Category: Primary Care Source Type: news